The physiological importance of this process is illustrated in that both genetic ablation2,3 and pharmacological inhibition4 of microsomal triglyceride transfer protein (MTP), the rate-limiting enzyme for VLDL assembly, lead to hepatic steatosis. The gene discussed is MTTP; the disease is Hepatic steatosis.